CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase IIIB, International, Single Group, Open Study to Define an Optimal Monitoring of IGF-1 in Children Treated With NutropinAq, Using a Novel Capillary Blood Collection Method
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00234533
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:28.932133+00:00
- Published At
- 2018-08-09T00:00:00+00:00
- Record Updated At
- 2019-12-09
- Results Posted At
- 2018-08-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Turner Syndrome", "Renal Insufficiency, Chronic", "Pituitary Diseases", "Dwarfism"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-12-09"- protocolSection.identificationModule.nctId
"NCT00234533"- protocolSection.identificationModule.officialTitle
"Phase IIIB, International, Single Group, Open Study to Define an Optimal Monitoring of IGF-1 in Children Treated With NutropinAq, Using a Novel Capillary Blood Collection Method"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-08-09"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.